YungShin Global Holding Corporation (TPE: 3705)
Taiwan
· Delayed Price · Currency is TWD 52.30
-0.10 (-0.19%)
Jan 20, 2025, 1:30 PM CST
YungShin Global Holding Revenue
YungShin Global Holding had revenue of 2.10B TWD in the quarter ending September 30, 2024, with 22.28% growth. This brings the company's revenue in the last twelve months to 7.82B, up 13.99% year-over-year. In the year 2023, YungShin Global Holding had annual revenue of 7.03B, down -3.88%.
Revenue (ttm)
7.82B
Revenue Growth
+13.99%
P/S Ratio
1.78
Revenue / Employee
n/a
Employees
n/a
Market Cap
13.93B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 7.03B | -283.83M | -3.88% |
| Dec 31, 2022 | 7.31B | -493.29M | -6.32% |
| Dec 31, 2021 | 7.81B | -279.61M | -3.46% |
| Dec 31, 2020 | 8.08B | -106.87M | -1.30% |
| Dec 31, 2019 | 8.19B | 677.85M | 9.02% |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
| Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| PharmaEssentia | 8.32B |
| Caliway Biopharmaceuticals | 49.98M |
| Bora Pharmaceuticals Co., LTD. | 16.71B |
| Lotus Pharmaceutical | 17.59B |
| Lumosa Therapeutics | 37.82M |
| Oneness Biotech | 112.20M |
| Polaris Group | 75.65M |
| Center Laboratories | 1.57B |